XML 179 R160.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities:          
Net income (loss)       $ (18,499,000) $ (9,712,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Share-based compensation $ 8,522,000 $ 1,259,000   12,231,000 4,906,000
Depreciation and amortization 1,083,000 1,396,000   5,390,000 2,406,000
Amortization of right-of-use assets 1,056,000 651,000   2,804,000 1,638,000
Change in fair value of derivative warrant liabilities 25,959,000 908,000   6,064,000 292,000
Other 0 71,000   107,000 886,000
Changes in operating assets and liabilities:          
Accounts receivable 2,017,000 (331,000)   382,000 (3,386,000)
Prepaid expenses and other assets (918,000) (537,000)   (1,031,000) (2,191,000)
Accounts payable 861,000 (926,000)   (692,000) (1,683,000)
Accrued expenses and other current liabilities       (399,000) 2,138,000
Accrued compensation and benefits       8,080,000 3,869,000
Operating lease liabilities       (3,536,000) (1,691,000)
Net cash used in operating activities (30,177,000) (1,243,000)   10,901,000 (2,528,000)
Cash Flows from Investing Activities:          
Cash paid for acquisitions, net of cash acquired         (13,114,000)
Loan to SharesPost         (3,000,000)
Purchases of property and equipment (11,000) 0     (13,000)
Capitalized internal-use software development costs (1,681,000) (117,000)   (1,054,000) (1,149,000)
Payment of deferred payments related to IRA Services acquisition         (6,097,000)
Net cash used in investing activities (1,692,000) (117,000)   (3,256,000) (23,373,000)
Cash Flows from Financing Activities:          
Offering costs paid (56,379,000) 0   (4,954,000)  
Proceeds from exercise of options 105,000 432,000   1,621,000 24,000
Proceeds from notes payable         25,566,000
Repayment of notes payable 0 (2,863,000)   (19,438,000) (27,688,000)
Cash paid to purchase equity awards       (23,000) (49,000)
Net cash provided by (used in) financing activities 159,591,000 (2,431,000)   26,581,000 39,380,000
Net increase (decrease) in cash and cash equivalents 127,722,000 (3,791,000)   34,226,000 13,479,000
Cash, cash equivalents and restricted cash, beginning of the period 76,404,000 42,179,000   42,179,000  
Cash, cash equivalents and restricted cash, end of the period 204,126,000 38,388,000 $ 42,179,000 76,404,000 42,179,000
Supplemental disclosures of cash flow information:          
Cash paid for interest 0 642,000   2,118,000 425,000
Supplemental disclosure of noncash financing activities:          
Deferred payments related to SharesPost acquisition         783,000
Forgiveness of loan to SharesPost in relation to acquisition         3,000,000
Issuance of Junior convertible preferred stock in relation to SharesPost acquisition         20,383,000
Issuance of Junior convertible preferred stock warrants in relation to SharesPost acquisition         1,285,000
Issuance of Class AA common stock in relation to SharesPost acquisition         44,817,000
Exchange of Class AA common stock for Series B convertible preferred stock       39,722,000  
Conversion of convertible notes into Series B-1 convertible preferred stock       111,000 9,940,000
Vesting of early exercised stock options and restricted stock awards       145,000 32,000
Warrant issued in connection with issuance of term loan         151,000
Warrant issued in connection with issuance of convertible notes payable         51,000
Motive Capital Corp [Member]          
Cash Flows from Operating Activities:          
Net income (loss)     (11,799,629) 9,363,744  
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Transaction cost - derivative liabilities     1,126,070    
Change in fair value of derivative warrant liabilities     10,659,080 (16,101,880)  
Gain on marketable securities, dividends and interest held in Trust Account     (20,525) (90,914)  
Changes in operating assets and liabilities:          
Prepaid expenses     (651,605) 377,371  
Accounts payable     961 4,357,744  
Accrued expenses     5,560 674,011  
Net cash used in operating activities     (680,088) (1,419,924)  
Cash Flows from Investing Activities:          
Cash deposited in Trust Account     (414,000,000)    
Net cash used in investing activities     (414,000,000)    
Cash Flows from Financing Activities:          
Repayment of note payable to related parties     (130,492)    
Proceeds received from initial public offering, gross     414,000,000    
Offering costs paid     (8,619,770)    
Proceeds received from private placement     11,080,000    
Proceeds from issuance of ordinary shares to initial shareholders     25,000    
Net cash provided by (used in) financing activities     416,354,738    
Net increase (decrease) in cash and cash equivalents     1,674,650 (1,419,924)  
Cash, cash equivalents and restricted cash, beginning of the period $ 254,726 $ 1,674,650 0 1,674,650  
Cash, cash equivalents and restricted cash, end of the period     1,674,650 $ 254,726 $ 1,674,650
Supplemental disclosure of noncash financing activities:          
Deferred underwriting commissions charged to additional paid-in capital in connection with initial public offering     14,490,000    
Offering costs included in accrued expenses     410,000    
Offering costs charged to additional paid-in capital in connection with the initial public offering     $ 880,262